Acute leukaemia: Making sense of a complex blood cancer

British Journal of Nursing

Volumn 21, Issue 2, 2012, Pages 76-83

  Meenaghan, Teresa ^a   Dowling, Maura ^b   Kelly, Mary ^c  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c Tullamore General Hospital   (Ireland)

Author keywords

Acute leukaemia; Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Haematology nursing

Indexed keywords

EID: 84856499772     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2012.21.2.76     Document Type: Article

References (64)

1. Aerts E, Fliedner M, Redmond K, Walton A (2010) Defining the scope of haematology nursing practice inEurope. Eur J Oncol Nurs 14(1): 55-60
2. AML 17 (2011) Acute myeloid leukaemia. Clinical trial 17.http://tiny.cc/oyuw9 (Accessed 7 December 2011)
3. Ashcroft AJ (2005) Leukaemias - acute. In: Peedell C, ed. Concise Clinical Oncology. Elsevier, Edinburgh
4. Atkinson J, Richardson C (2006) The leukaemias. In: Grundy M, ed. Nursing in Haematology Oncology. Elsevier, Edinburgh
5. Bardiaux L, Assari S, Babinet J, Cavelier B, Raba M, Redersdorff JC, Roubinet F (2007) Transfusion protocols in hematopoietic stem cell allogeneic transplantation. Transfus Clin Biol 14(1): 94-9 (Pubitemid 46887576)
6. Blumenreich MS (1990) The white blood cell and differential count. In: Walker K, Hall WD, Hurst JW, eds. ClinicalMethids: the History Physical Laboratory Examination. 3rdedn. Butterworth, Boston
7. Cancer Research UK (2011) Cancer in the UK 2011. http://tiny.cc/wuog8 (Accessed 21 December 2011)
8. Cazzaniga G, Valsecchi MG, Gaipa G, Conter V, Biondi A(2011) Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia. Br J Haematol 155(1): 45-52
9. Eden TOB, Pieters R, Richards S (2009) Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: A systematic review and meta-analysis. Br J Haematol 145(3): 376-88
10. Estcourt LJ, Stanworth SJ, Murphy MF (2011) Platelet transfusions for patients with haematological malignancies: Who needs them? Br J Haematol 154(4): 425-40
11. Estey E (2009) AML in older patients: are we making progress? Best Pract Res Clin Haematol 22(4): 529-36
12. Faderl S, O'Brien S, Pui CH, Stock W, Wetzler M, Hoelzer D, Kantarjian HM (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116(5): 1165-76
13. Flohr T, Schrauder A, Cazzaniga G et al (2008) Minimal residual disease-directed risk stratification using realtime quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 22(4): 771-82 (Pubitemid 351552626)
14. Friis LS, Elverdam B, Schmidt KG (2003) The patient's perspective: A qualitative study of acute myeloid leukaemia patients' need for information and their information-seeking behaviour. Suppor Care Cancer 11(3): 162-70 (Pubitemid 36733810)
15. Gardner A, Mattiuzzi G, Faderl S et al (2008) Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 26(35): 5684-8
16. Gray A (2006) Blood component support. In Brighton D, Wood M, eds. The Royal Marsden Hospital Handbook of Cancer Chemotherapy. Elsevier, Edinburgh
17. Held-Warmkessel J (2011) Taming three high-risk chemotherapy complications. Nursing 41(11): 30-7
18. Hill QA (2010) Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 24(1): 17-25
19. Hu SW, Cotliar J (2011) Acute graft-versus-host disease following hematopoietic stem-cell transplantation. Dermatologic Therapy 24(4): 411-23
20. Hunger SP, Raetz EA, Loh ML, Mullighan CG (2011) Improving outcomes for high-risk ALL: translating new discoveries into clinical care. Paediatr Blood Cancer 56(6): 984-93
21. Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S (2005) Reduced-intensity allogeneic hematopoitic stem cell transplantation for acute leukaemia. Bone Marrow Transplant 36(1): 565-74 (Pubitemid 43115011)
22. Koenigsmann M, Koehler K, Regner A, Franke A, Frommer J (2006) Facing mortality: A qualitative in-depth interview study on illness perception, lay theories and coping strategies of adult patients with acute leukemia 1 week after diagnosis. Leuk Res 30(9): 1127-34 (Pubitemid 44037085)
23. Kohli R, Xu, W, Brandwein J et al (2010) Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR. Bone Marrow Transplant 45(7): 1256-8
24. Krawczyk J, Ansar N, Swords R et al (2010) Clofarabine in the treatment of poor risk acute myeloid leukaemia. Haematol Oncol 28(3): 118-23
25. Kwaan HC, Huyck T (2010) Thromboembolic and bleeding complications in acute leukemia. Expert Rev Hematol 3(6):719-30
26. Leventakos K, Lewis RE, Kontoyiannis DP (2010) Fungal infections in leukemia patients: How do we prevent and treat them? Clin Infect Dis 50(3): 405-15
27. Manitta VJ, Philip JAM, Cole-Sinclair MF (2010) Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med 13(8): 1021-5
28. Marrs JA (2006) Care of patients with neutropenia. Clin J Oncol Nurs 10(2): 164-6
29. McGrath P (2001) Findings on the impact of treatment for childhood acute lymphoblastic leukaemia on family relationships. Child and Family Social Work 6(3): 229-37
30. McGrath P, Holewa H (2007) Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care 16(2): 164-71
31. McGrath P, Holewa H (2006) Missed opportunities: nursing insights on end-of-life care for haematology patients. Int J Nurs Pract 12(5): 295-301
32. McGrath S, Chatterjee F, Whiteley C, Ostermann M (2010) ICU and 6-month outcome of oncology patients in the intensive care unit. QJM 103(6): 397-403
33. Meenaghan T, Dowling M (2010) Receiving treatment for acute leukaemia: elderly patients lived experience. Br J Nurs 19(1): 52-7
34. Mitchell MD, Anderson BJ, Williams K, Umscheid CA (2009) Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs 65(10): 2007-21
35. Nirenberg A, Bush AP, Davis A, Friese CR, Gillespie TW, Rice RD (2006a) Neutropenia: State of the knowledge part I. Oncol Nurs Forum 33(6): 1193-201
36. Nirenberg A, Bush AP, Davis A, Friese CR, Gillespie TW, Rice RD (2006b) Neutropenia: state of the knowledge part II. Oncol Nurs Forum 33(6): 1202-8
37. Nodehi RS, Gharib B, Sharifian R, Emami A, Moghadaszadeh M, Sardashti S (2010) A study of the complete response rate with a combination of high dose cytarabine and cladribine in refractory and relapsed acute leukaemia. International Journal of Haematology-Oncology and Stem Cell Research 4(1): 5-8
38. O'Donnell MR (2004) Acute leukaemias. In: Pazdur R, Coia LR, Hoskins WJ, Wagnan LD, eds. Cancer Management: Multidisciplinary Approach. 8th edn. CMP New York
39. O'Donnell MR, Abboud CN, Altman J et al (2011) Acute myeloid leukaemia. Journal of the National Comprehensive Cancer Network 9(2): 280-317
40. Pieters R, Schrappe M, De Lorenzo P et al (2007) Atreatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant- 99): an observational study and a multicentre randomised trial. Lancet 370(9583): 240-50 (Pubitemid 47082422)
41. Plasschaert SLA, Kamps WA, Vellenga E, de Vries EGE, de Bont ESJM (2004) Prognosis in childhood and adult acute lymphoblastic leukaemia: A question of maturation? Cancer Treat Revi 30(1): 37-51 (Pubitemid 38240087)
42. Pollyea DA, Kohrt HE, Medeiros BC (2011) Acute myeloid leukaemia in the elderly: A review. Br J Haematol 152(5): 524-42
43. Prebet T, Etienne A, Devillier R et al (2011) Improved outcomes of patients with low-and intermediaterisk cytogenics acute myeloid leukaemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study. Cancer 117(5): 974-81
44. Pui CH, Robison LL, Look AT (2008) Acute lymphoblastic leukaemia. Lancet 371(9617): 1030-43 (Pubitemid 351389536)
45. Pui CH (2010) Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 109(11): 777-87
46. Ravandi F, O'Brien S, Thomas D et al (2010) First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood 116(12): 2070-7
47. Ravandi F (2011) Primary refractory acute myeloid leukaemia - in search of better definitions and therapies/ Br J Haematol 155(4): 413-9
48. Rebulla P (2005) A mini-review on platelet refractoriness. Haematologica 90(2): 247-253
49. Redaelli A, Laskin BL, Stephens JM et al (2005) A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care 14(1): 53-62 (Pubitemid 40314386)
50. Rüping MJGT, Vehreschild, JJ, Cornely OA (2008) Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68(14): 1941-62
51. Sanz MA, Grimwade D, Tallman MS et al (2009) Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 113(9): 1875-91
52. Sayed D, Bakry R, El-Sharkawy N, Zahran A, Khalaf, MR (2011) Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia. J Clin Apher26(1): 23-8
53. Secker-Walker LM, Chessels JM, Stewart EL, Swansbury GL, Richards S, Lawler SD (1989) Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow up. Br J Haematol 72(3): 336-42 (Pubitemid 19180042)
54. Seiter K (2011) Acute lymphoblastic leukemia treatment protocols. http://tiny.cc/aicqd (Accessed 21 December 2011)
55. Selwood K, Pizer B, Gibson B, Skinner R (2008) Vascular access for daunorubicin during childhood acute lymphoblastic leukaemia induction treatment: A UKCCSG supportive care group and MRC childhood leukaemia working party survey. Eur J Oncol Nurs 12(5): 476-8
56. Seshadri S, Baumann MA (2008) Reverse isolation for neutropenic patients. Community Oncology 5(11): 628-32
57. Stalfelt AM, Brodinn H, Pettersson H, Eklüf A (2003) The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk Res 27(6): 481-8 (Pubitemid 36315778)
58. Stone RM (2002) The difficult problem of acute myeloid leukaemia in the older adult. CA Cancer J Clin 52(6): 363-71 (Pubitemid 35446607)
59. Temming P, Jenney MEM (2010) The neurodevelopmental sequelae of childhood leukaemia and its treatment. ArchDis Child 95(11): 936-40
60. Teuffel O, Stanulla M, Cario G et al (2008) Anemia and survival in childhood acute lymphoblastic leukaemia. Haemotologica 93(11): 1652-7
61. Treleaven J, Stephens M (2005) Myeloma and the acute and chronic leukaemias. In: Brighton D, Wood M, eds. TheRoyal Marsden Hospital Handbook of Cancer Chemotherapy. Elsevier Churchill Livingstone, Edinburgh: 467-94
62. Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5): 937-51
63. Vardiman JW (2010) The World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues: An overview with mphasis on the myeloid neoplasms. Chem Biol Interact 184(1-2): 16-20
64. Zohren F, Czibere A, Bruns I et al (2009) Fludarabine, amsacrine, high-dose cytarabine and 12Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia. Bone Marrow Transplant 44(12): 785-92